Last reviewed · How we verify
NCT03437317: PTL
Emotional Perceptual Training as a Treatment for Social Anxiety: Behavioral and Neural Evidence.
NA trial testing Perceptual Retraining in Anxiety Disorders and Symptoms in 154 participants. Completed in 15 December 2016.
15 December 2016
Quick facts
| Lead sponsor | Florida State University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 154 |
| Start date | 1 November 2014 |
| Primary completion | 15 December 2016 |
| Estimated completion | 15 December 2016 |
Drugs / interventions tested
- Perceptual Retraining
- Gender Discrimination
Conditions studied
- Anxiety Disorders and Symptoms — all drugs for Anxiety Disorders and Symptoms →
- Social Anxiety Disorder — all drugs for Social Anxiety Disorder →
Sponsor
Florida State University
Who can join
Adults 18 to 35, any sex, with Anxiety Disorders and Symptoms or Social Anxiety Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The Perceptual Training Study is a series of studies performed with the purpose of identifying a potential avenue for treatment of mood disorders, particularly anxiety-based mood disorders. The underlying theme is that neural representations may be threat-oriented, and may also be generalized to non-threatening cues by means of similarity to threatening representations. These may result in anxiety symptoms from innocuous cues. The idea behind the perceptual training is to create a divorce between the threat representations and cues which should be considered non-threatening, enhancing perceptual acuity and potentially reducing anxiety symptoms.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03437317
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Anxiety Disorders and Symptoms
Currently open trials in the same condition.
- NCT05067998 — The Benefits of Natural Medicine, Vitamin IV Therapy and Supplements: Maintaining Good Health Through Nature · recruiting
- NCT05821634 — Personalizing Treatment Delivery · NA · recruiting
- NCT06138730 — Evaluating a Virtual Mentoring Program Plus Mental Health Videos for Teens · NA · active not recruiting
- NCT06356090 — SPACE: a Parent-based Treatment for Pediatric OCD · NA · recruiting
- NCT05836090 — Family Spirit Strengths · NA · recruiting
Other Florida State University trials
Trials by the same sponsor.
- NCT06127914 — Learning Early Infant Feeding Cues · NA · not yet recruiting
- NCT06015581 — Scaling Up Implementation Strategies to Improve the DIAGNOSE and PREVENT Pillars for Young MSM in Florida · NA · not yet recruiting
- NCT07467473 — Causal Role of Rostromedial Prefrontal Cortex for Positive Savoring in Depression · NA · enrolling by invitation
- NCT07221448 — Sodium vs Potassium Education to Improve Vascular Health · NA · recruiting
- NCT07415941 — MBM and taVNS for Low Back Pain and Depressive Symptoms · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03437317 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Florida State University
- Last refreshed: 19 February 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03437317.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing